ALPHATAC
LIVE

Serial Number

97701222

Owner

VIB VZW

Attorney

Clifford D. Hyra

Filing Date

Dec 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ALPHATAC Trademark

Serial Number: 97701222 • Registration: 8026854

ALPHATAC is a trademark filed by VIB VZW on December 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VIB VZW (8 trademarks)

Suzanne Tassierstraat 1
Gent 9052 , BE

Entity Type: 99

Trademark Details

Filing Date

December 2, 2022

Registration Date

November 18, 2025

Published for Opposition

March 11, 2025

Goods & Services

Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest control, fungicides, germicides and herbicide, and not relating to means for diagnostics

Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradation in cancer, immunological disease, and autoimmunological disease; Medical preparations and substances, namely, liquid, solid, and lyophilized protein-based preparations for medical uses and treatments for cancer, immunological disease, and autoimmunological disease; Medical and veterinary preparations and substances in the nature of liquid, solid, and lyophilized protein-based biotherapeutic preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, pharmaceutical preparations for the treatment of disease, namely, cancer, immunological disorders, and autoimmunological disorders in humans and animals; bioculture preparations for pharmaceutical, medical, and veterinary purposes, namely, cultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discovery, namely, clinical medical reagents; all of the aforesaid goods excluding means for pest control, fungicides, germicides and herbicides and excluding means for diagnostics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 29, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Oct 29, 2025 IUCN
REVIEW OF CORRESPONDENCE COMPLETE
Oct 29, 2025 CORV
TEAS DELETE 1(B) BASIS RECEIVED
Sep 24, 2025 D1BR
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 22, 2025 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 19, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2024 CNSA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 30, 2024 XELR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 30, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 31, 2024 GNFN
FINAL REFUSAL E-MAILED
May 31, 2024 GNFR
FINAL REFUSAL WRITTEN
May 31, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2022 NWOS
NEW APPLICATION ENTERED
Dec 6, 2022 NWAP